Literature DB >> 32852671

Viscoelastic properties of clot formation and their clinical impact in East Asian versus Caucasian patients with stable coronary artery disease: a COMPARE-RACE analysis.

Young-Hoon Jeong1,2, Bliden Kevin3, Jong-Hwa Ahn4, Rahul Chaudhary3, Min Gyu Kang5, Hyun Woong Park5, Jin-Sin Koh6, Yongwhi Park4,5, Udaya S Tantry3, Paul A Gurbel7.   

Abstract

Compared with Caucasian patients, East Asian patients with coronary artery disease (CAD) have demonstrated better clinical outcomes. We sought to compare the viscoelastic properties of clot formation and their impact on clinical outcomes in East Asian vs. Caucasian patients. We analyzed age- and sex-matched East Asian and Caucasian patients with stable CAD (n = 249 each). Viscoelastic properties of clot formation were assessed with thromboelastography (TEG), and 3-year clinical outcomes were recorded. Major adverse cardiovascular events (MACE) were defined as a composite of cardiovascular death, myocardial infarction, or stroke. Compared with Caucasians, East Asians showed lower platelet-fibrin clot strength (PFCS) (maximum amplitude [MA]: 61.8 ± 7.9 vs. 65.4 ± 5.0 mm, p < 0.001). In a multivariate analysis, high PFCS (defined as MA ≥ 68 mm) was significantly associated with MACE occurrence (odds ratio 6.27, 95% CI 2.41 to 16.30, p < 0.001). East Asians vs. Caucasians had lower prevalence of high PFCS (odds ratio 0.50, 95% CI 0.27 to 0.93, p = 0.028). In conclusion, this is the first study to demonstrate different viscoelastic properties of clot between East Asian and Caucasian patients with stable CAD. The platelet-fibrin clot strength was significantly associated with MACE in these patients and was significantly lower in East Asians. Future studies are warranted to further explore the mechanistic explanation and clinical importance of these findings.

Entities:  

Keywords:  Cardiovascular events; Caucasians; Coronary artery disease; East asians; Platelet -fibrin clot strength

Year:  2021        PMID: 32852671     DOI: 10.1007/s11239-020-02240-2

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  2 in total

1.  The Impact of platelet-fibrin clot strength on occurrence and clinical outcomes of peripheral artery disease in patients with significant coronary artery disease.

Authors:  Jae Seok Bae; Jong-Hwa Ahn; Jeong Yoon Jang; Sang Young Cho; Min Gyu Kang; Kye-Hwan Kim; Hyun Woong Park; Jin-Sin Koh; Yongwhi Park; Seok-Jae Hwang; Choong Hwan Kwak; Jin-Yong Hwang; Udaya S Tantry; Paul A Gurbel; Young-Hoon Jeong
Journal:  J Thromb Thrombolysis       Date:  2020-04-11       Impact factor: 2.300

2.  Heart Disease and Stroke Statistics-2020 Update: A Report From the American Heart Association.

Authors:  Salim S Virani; Alvaro Alonso; Emelia J Benjamin; Marcio S Bittencourt; Clifton W Callaway; April P Carson; Alanna M Chamberlain; Alexander R Chang; Susan Cheng; Francesca N Delling; Luc Djousse; Mitchell S V Elkind; Jane F Ferguson; Myriam Fornage; Sadiya S Khan; Brett M Kissela; Kristen L Knutson; Tak W Kwan; Daniel T Lackland; Tené T Lewis; Judith H Lichtman; Chris T Longenecker; Matthew Shane Loop; Pamela L Lutsey; Seth S Martin; Kunihiro Matsushita; Andrew E Moran; Michael E Mussolino; Amanda Marma Perak; Wayne D Rosamond; Gregory A Roth; Uchechukwu K A Sampson; Gary M Satou; Emily B Schroeder; Svati H Shah; Christina M Shay; Nicole L Spartano; Andrew Stokes; David L Tirschwell; Lisa B VanWagner; Connie W Tsao
Journal:  Circulation       Date:  2020-01-29       Impact factor: 29.690

  2 in total
  2 in total

1.  Race-Related disparities in COVID-19 thrombotic outcomes: Beyond social and economic explanations.

Authors:  Rahul Chaudhary; Kevin P Bliden; Rolf P Kreutz; Young-Hoon Jeong; Udaya S Tantry; Jerrold H Levy; Paul A Gurbel
Journal:  EClinicalMedicine       Date:  2020-11-20

2.  An Older Thrombus Delays Reperfusion after Mechanical Thrombectomy for Ischemic Stroke.

Authors:  Takaya Kitano; Yumiko Hori; Shuhei Okazaki; Yuki Shimada; Takanori Iwamoto; Hideaki Kanki; Shintaro Sugiyama; Tsutomu Sasaki; Hajime Nakamura; Naoki Oyama; Taku Hoshi; Goichi Beck; Hiroki Takai; Shunji Matsubara; Hiroya Mizuno; Hirotake Nishimura; Ryo Tamaki; Junichi Iida; Jiro Iba; Masaaki Uno; Haruhiko Kishima; Hiroaki Fushimi; Satoshi Hattori; Shigeo Murayama; Eiichi Morii; Manabu Sakaguchi; Yoshiki Yagita; Takeshi Shimazu; Hideki Mochizuki; Kenichi Todo
Journal:  Thromb Haemost       Date:  2021-07-06       Impact factor: 6.681

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.